Quest Diagnostics (DGX) Gross Margin (2009 - 2026)
Quest Diagnostics' (DGX) quarterly Gross Margin came in at 33.75% in Q2 2026, down 40.0% year-over-year from 56.25% in Q2 2025, and up 3.72% quarter-over-quarter from 32.54% in Q1 2026.
Powered by 
Analysis
Quest Diagnostics (DGX) Gross Margin (2009 - 2026) Analysis & Trends
Quest Diagnostics has disclosed Gross Margin across 18 years of filings, most recently posting 33.75% for Q2 2026.
- In Q2 2026, Gross Margin fell 40.0% year-over-year to 33.75%; the TTM figure through Jun 2026 stood at 33.11% (up 9.0% YoY), while the FY2025 annual figure was 33.21%, up 35.0% from the prior year.
- Gross Margin came in at 33.75% for Q2 2026 at Quest Diagnostics, up from 32.54% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 36.96% in Q1 2022 to a low of 32.17% in Q4 2023.
- Average Gross Margin over 5 years is 33.4%, with a median of 32.96% recorded in 2023.
- Year-over-year, Gross Margin plunged 490 bps in 2022 and jumped 110 bps in 2025.
- Over 5 years, Gross Margin stood at 32.49% in 2022, then dropped by 1 bps to 32.17% in 2023, then increased by 2 bps to 32.74% in 2024, then decreased by 1 bps to 32.43% in 2025, then rose by 4 bps to 33.75% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 33.75% in Q2 2026, 32.54% in Q1 2026, and 32.43% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 64.58% |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 33.75% |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 29.80% |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 65.39% |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 71.70% |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 69.16% |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 55.38% |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 70.45% |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 71.82% |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 72.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.75% |
| Mar 31, 2026 | 32.54% |
| Dec 31, 2025 | 32.43% |
| Sep 30, 2025 | 33.70% |
| Jun 30, 2025 | 34.15% |
| Mar 31, 2025 | 32.54% |
| Dec 31, 2024 | 32.74% |
| Sep 30, 2024 | 32.60% |
| Jun 30, 2024 | 33.54% |
| Mar 31, 2024 | 32.59% |
| Dec 31, 2023 | 32.17% |
| Sep 30, 2023 | 32.85% |
| Jun 30, 2023 | 33.88% |
| Mar 31, 2023 | 33.08% |
| Dec 31, 2022 | 32.49% |
| Sep 30, 2022 | 34.92% |
| Jun 30, 2022 | 34.33% |
| Mar 31, 2022 | 36.96% |
| Dec 31, 2021 | 37.39% |
| Sep 30, 2021 | 39.80% |